Epilepsy is a complex disorder with both obvious and hidden symptoms, and some individuals are at a higher risk due to ...

Based on alignment gained with FDA under the Regenerative Medicine Advanced Therapy (RMAT) designation, Neurona plans to conduct the Phase 3 ...

The drug fenfluramine has been recommended by the National Institute for Health and Care Excellence (NICE) for children with ...

Join the epilepsy community for Purple Day® on March 26, a global initiative to raise epilepsy awareness and support the millions of people living with epilepsy worldwide. Approximately 65 million ...

Andrew Wilner speaks with fellow neurologist Karine Abou Khaled about her recent study on a 15-minute subdermal EEG with a simplified module for critically ill patients vs a full-head 24-hour EEG.

Larson's pause on Monday was initially attributed to adverse effects to medication. After more tests, doctors identified it ...

SNS Insider Reports: Increasing Awareness, Advancements in Drug Development, and government Initiatives fuel market Growth at a CAGR of 4.06% from 2024-2032 ...

A complex partial seizure, also known as a focal impaired awareness seizure, is described as a type of epilepsy in adults that causes a change in consciousness and often lasts between 30 seconds and a ...

Epilepsy Surgery Market Poised for Steady Growth Driven by Advancements in Surgical Procedures and Rising Prevalence of Epilepsy.Pune, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Epilepsy Surgery Market Size & ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Children of women with epilepsy prescribed antiseizure medications do not have significant neurodevelopmental differences at age 6 years.

Awareness can pave the way for greater understanding, acceptance, and, ultimately, a better quality of life for those living ...